Skip to main content
. 2018 May 18;57(20):3007–3010. doi: 10.2169/internalmedicine.0876-18

Figure 1.

Figure 1.

Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy performed 10 months after the symptom onset. 1) Heart and 2) mediastinum. Early- (A) and late-phase (B) MIBG scans show a decreased heart-to-mediastinum ratio (early phase 1.65; late phase 1.53) (institutional cut-off value, 2.0).